This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
The early identification and management of fatty liver is a critical step in preventing the progression of the disease and its associated complications. Fatty liver, also known as non-alcoholic fatty liver disease (NAFLD), is an increasingly common chronic liver disorder, characterized by excess fat accumulation in the liver. It can be caused by obesity, diabetes, high cholesterol, and high blood pressure. Early identification of fatty liver is essential for timely intervention and effective management. The initial step in screening for fatty liver is a physical examination. A doctor may perform a physical exam, looking for signs of abdominal discomfort, enlarged liver, and signs of chronic liver disease. Blood tests, such as liver function tests, can be used to measure the amount of fat in the liver and can help identify if there is any underlying liver damage. Ultrasound or MRI can be used to visualize the liver and detect any abnormalities in the liver structure. Once fatty liver is identified, it is important to manage the condition to prevent further damage and complications. Lifestyle modifications are the cornerstone of management and should include weight loss, regular exercise, and a healthy diet low in saturated fat, cholesterol, and sugar. Medications, such as statins, may also be prescribed to reduce cholesterol levels. In some cases, a liver transplant may be necessary. It is important to note that fatty liver is a progressive disorder and can progress to cirrhosis and liver failure if left untreated. Early identification and management is key to preventing disease progression and its associated complications. It is important to speak with a doctor if you have any concerns about fatty liver.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States